These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2936343)

  • 1. Effect of synthetic atrial natriuretic factor on arginine vasopressin release by the rat hypothalamo-neurohypophysial complex in organ culture.
    Januszewicz P; Thibault G; Garcia R; Gutkowska J; Genest J; Cantin M
    Biochem Biophys Res Commun; 1986 Jan; 134(2):652-8. PubMed ID: 2936343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vasopressin and aldosterone release by atrial natriuretic peptide in conscious rabbits.
    Gerstberger R; Schütz H; Luther-Dyroff D; Keil R; Simon E
    Exp Physiol; 1992 Jul; 77(4):587-600. PubMed ID: 1388030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion.
    Samson WK; Aguila MC; Martinovic J; Antunes-Rodrigues J; Norris M
    Peptides; 1987; 8(3):449-54. PubMed ID: 2958784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release.
    Crandall ME; Gregg CM
    Neuroendocrinology; 1986; 44(4):439-45. PubMed ID: 2950334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the effect of nicotine on vasopressin and atrial natriuretic factor in the rabbit.
    Larose P; Ong H; Januszewicz P; Cantin M; du Souich P
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1093-7. PubMed ID: 2908045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long-Evans rats.
    Rossi NF
    J Physiol; 1993 Feb; 461():501-11. PubMed ID: 8350273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prostaglandins on the release of arginine vasopressin from the guinea pig hypothalamo-neurohypophyseal complex in organ culture.
    Ishikawa S; Saito T; Yoshida S
    Endocrinology; 1981 Jan; 108(1):193-8. PubMed ID: 7460817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atrial natriuretic peptide on the release of beta-endorphin from rat hypothalamo-neurohypophysial complex.
    Ikeda Y; Tanaka I; Oki Y; Ikeda Y; Yoshimi T
    Endocrinol Jpn; 1989 Oct; 36(5):647-53. PubMed ID: 2533554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat.
    Poole CJ; Carter DA; Vallejo M; Lightman SL
    J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro.
    Rossi NF; Kim JK; Summers SN; Schrier RW
    Life Sci; 1997; 61(23):2271-82. PubMed ID: 9408050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nitric oxide inhibition on secretion of atrial natriuretic factor in isolated rat heart.
    Melo LG; Sonnenberg H
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H306-11. PubMed ID: 8769765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of calcium in osmotic and nonosmotic release of vasopressin from rat organ culture.
    Ishikawa S; Schrier RW
    Am J Physiol; 1983 May; 244(5):R703-8. PubMed ID: 6405631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of atrial natriuretic factor on arginine-8-vasopressin and oxytocin levels in various brain regions and plasma.
    Laczi F; Vecsernyés M; Kovács GL; Penke B; Jójárt I; Janáky T; Telegdy G; László FA
    Exp Clin Endocrinol; 1988 Mar; 92(3):328-34. PubMed ID: 2978124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
    Watanabe H; Lau DC; Guyn HL; Wong NL
    Clin Invest Med; 1997 Aug; 20(4):211-23. PubMed ID: 9258576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic and binding effects of atrial natriuretic factor in glomeruli and nephrons.
    Kim JK; Summer SN; Durr J; Schrier RW
    Kidney Int; 1989 Mar; 35(3):799-805. PubMed ID: 2540377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 (IL-1) stimulates arginine vasopressin (AVP) release from superfused rat hypothalamo-neurohypophyseal complexes independently of cholinergic mechanism.
    Nakatsuru K; Ohgo S; Oki Y; Matsukura S
    Brain Res; 1991 Jul; 554(1-2):38-45. PubMed ID: 1681990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosterone inhibition of osmotically stimulated vasopressin from hypothalamic-neurohypophysial explants.
    Papanek PE; Sladek CD; Raff H
    Am J Physiol; 1997 Jan; 272(1 Pt 2):R158-62. PubMed ID: 9039004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholinergic antagonists on basal and osmotically stimulated vasopressin release in compartmentalized hypothalamo-neurohypophysial explants.
    Gregg CM
    Neuroendocrinology; 1986; 44(3):378-83. PubMed ID: 2880306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A compartmentalized, organ-cultured hypothalamo-neurohypophysial system for the study of vasopressin release.
    Gregg CM; Sladek CD
    Neuroendocrinology; 1984 May; 38(5):397-402. PubMed ID: 6728121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic atrial natriuretic factor induces release (possibly receptor-mediated) of vasopressin from rat posterior pituitary.
    Januszewicz P; Gutkowska J; De Lean A; Thibault G; Garcia R; Genest J; Cantin M
    Proc Soc Exp Biol Med; 1985 Feb; 178(2):321-5. PubMed ID: 3155864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.